168
LARYNGEAL RECALIBRATION THERAPY RESULTS IN SYMPTOM IMPROVEMENT FOR PATIENTS WITH LARYNGEAL SYMPTOMS & GASTROESOPHAGEAL REFLUX DISEASE
Date
May 18, 2024
Tracks
Related Products
Advances in Diagnosis of Esophageal Pathophysiology and GERD
SOCIETY: AGA Updates in esophageal diagnostics
VONOPRAZAN FOR THE TREATMENT OF HEARTBURN IN NON-EROSIVE REFLUX DISEASE: A RANDOMIZED TRIAL
BACKGROUND: Proton pump inhibitors (PPIs) are the mainstay of therapy for non-erosive reflux disease (NERD). Potassium-competitive acid blockers (PCABs) have more potent and rapid inhibition of gastric acid secretion than PPIs…
Donald O. Castell, MD, Lecture: GERD Diagnosis from Lyon to Chicago to Padova: Do All Roads Eventually Lead to Rome?
The diagnosis of GERD is being updated using the Lyon Consensus 2.0 (updated in 2023), which takes into account a modern diagnosis of GERD, symptoms of GERD, optimal testing as well as metrics and thresholds used to diagnose conclusive GERD…